|نسخه تمام متن
|5 صفحه PDF
• Neurocognitive impairment (NCI) negatively influences addiction treatment outcomes.
• Neuropsychological Impairment Scale (NIS), a self-report measure, was originally developed to assess NCI among patients in psychiatric treatment settings.
• We examined the factor structure of the NIS using data from participants enrolled in methadone maintenance therapy.
• The revised 9-factor measure - now referred to as the Brief Inventory of Neuro-cognitive Impairment (BINI) - showed a diverse set of factors with good to excellent reliability.
• Results suggest the potential utility of using the BINI in the context of addiction treatment.
The present study examines the factor structure of the existing Neuropsychological Impairment Scale (NIS) through the use of exploratory factor analysis (EFA). The NIS is a brief, self-report measure originally designed to assess neurocognitive impairment (NCI) by having patients rate a range of items that may influence cognitive functioning. Stabilized patients on methadone maintenance therapy (MMT; N = 339) in New Haven, CT who reported drug- or sex-related HIV risk behaviors in the past 6 months were administered the full 95-item NIS. An EFA was then conducted using principal axis factoring and orthogonal varimax rotation. The EFA resulted in retaining 57 items, with a 9-factor solution that explained 54.8% of the overall variance. The revised 9-factor measure - now referred to as the Brief Inventory of Neuro-cognitive Impairment (BINI) - showed a diverse set of factors with excellent to good reliability (i.e., F1 α = 0.97 to F9 α = 0.73). This EFA suggests the potential utility of using the BINI in the context of addiction treatment. Further research should examine the utility of this tool within other clinical care settings.
Journal: Journal of Substance Abuse Treatment - Volume 63, April 2016, Pages 61–65